Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies

Fetal Diagnosis and Therapy

Volumn 35, Issue 3, 2014, Pages 204-211

  Del Mar Gil, Maria ^a   Quezada, Maria Soledad ^a   Bregant, Barbara ^a   Syngelaki, Argyro ^a   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Fetal aneuploidy; First trimester screening; Non invasive prenatal testing; Trisomy 21; Twin pregnancy

Indexed keywords

ADULT; ARTICLE; CELL FREE SYSTEM; DNA DETERMINATION; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MIDDLE AGED; RISK ASSESSMENT; SCORING SYSTEM; TRISOMY; TRISOMY 13; TRISOMY 18; TRISOMY 21; TWIN PREGNANCY; YOUNG ADULT; GENETICS; MATERNAL SERUM SCREENING TEST; PHYSIOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TWINS;

DNA;

ADULT; CELL-FREE SYSTEM; DNA; FEMALE; HUMANS; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY, TWIN; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRISOMY;

EID: 84906874410     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000356495     Document Type: Article

References (27)

1. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH: Analysis of cell-free DNA in maternal blood in screening for aneu-ploidies: meta-analysis. Fetal Diagn Ther, in press.
2. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM: Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large-scale validity study. BMJ 2011; 342:c7401.
3. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, Dean J, Tang L, Hutchison D, Lu T, Wang H, Angkachatchai V, Oeth P, Cantor CR, Bombard A, van den Boom D: Noninvasive detection of fetal tri-somy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011; 204:205.e1-11.
4. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA: DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13:913-920.
5. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP: Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011; 57:1042-1049.
6. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH: Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 322.e1-5.
7. Qu JZ, Leung TY, Jiang P, Liao GJ, Cheng YK, Sun H, Chiu RW, Chan KC, Lo YM: Nonin-vasive prenatal determination of twin zygos-ity by maternal plasma DNA analysis. Clin Chem 2013; 59:427-435.
8. Leung TY, Qu JZ, Liao GJ, Jiang P, Cheng YK, Chan KC, Chiu RW, Lo YM: Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing. Prenat Diagn 2013; 33:675-681.
9. Struble CA, Syngelaki A, Oliphant A, Song K, Nicolaides KH: Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis. Fetal Diagn Ther, DOI: 10.1159/000355653.
10. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH: The lambda sign at 10-14 weeks of gestation as a predictor of chorionic-ity in twin pregnancies. Ultrasound Obstet Gynecol 1996; 7:421-423.
11. Robinson HP, Fleming JE: A critical evaluation of sonar crown-rump length measurements. Br J Obstet Gynaecol 1975; 182:702-710.
12. Nicolaides KH: Screening for fetal aneuploi-dies at 11 to 13 weeks. Prenat Diagn 2011; 31: 7-15.
13. Wright D, Syngelaki A, Staboulidou I, Cruz Jde J, Nicolaides KH: Screening for trisomies in di-chorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Prenat Diagn 2011; 31: 16-21.
14. Madsen HN, Ball S, Wright D, Tørring N, Pe-tersen OB, Nicolaides KH, Spencer K: A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester. Ultrasound Obstet Gynecol 2011; 37:38-47.
15. Gil MM, Quezada MS, Bregant G, Ferraro M, Nicolaides KH: Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 2013; 42:34-40.
16. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A: Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gy-necol 2012; 206:319.e1-9.
17. Snijders RJM, Sebire NJ, Cuckle H, Nicolaides KH: Maternal age and gestational age-specific risks for chromosomal defects. Fetal Diagn Ther 1995; 10:356-367.
18. Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH: Maternal age and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999; 13:167-170.
19. Ashoor G, Syngelaki A, Poon LCY, Rezende JC, Nicolaides KH: Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 20124; 1: 26-32.
20. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE: DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012; 32:730-734.
21. Lau TK, Jiang F, Chan MK, Zhang H, Lo PS, Wang W: Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2013; 26:434-437.
22. Fell DB, Joseph KS: Temporal trends in the frequency of twins and higher-order multiple births in Canada and the United States. BMC Pregnancy Childbirth 2012; 12:103-109.
23. Royal College of Obstetricians and Gynaecologists: Amniocentesis and Chorionic Villus Sampling. Green-Top Guideline No. 8. London, RCOG Press, 2010.
24. Evans MI, Goldberg JD, Dommergues M, Wapner RJ, Lynch L, Dock BS, Horenstein J, Golbus MS, Rodeck CH, Dumez Y, Holzgreve W, Timor Tritsch I, Johnson MP, Isada NB, Monteagudo A, Berkowitz RL: Efficacy of second-trimester selective termination for fetal abnormalities: International collaborative experience among the world's largest centers. Am J Obstet Gynecol 1994; 171:90-94.
25. Agarwal K, Alfirevic Z: Pregnancy loss after chorionic villus sampling and genetic amnio-centesis in twin pregnancies: a systematic review. Ultrasound Obstet Gynecol 2012; 40: 128-134.
26. National Institute for Health and Clinical Excellence: Multiple pregnancy. NICE Clinical Guideline 129, 2011.
27. Nicolaides KH, Syngelaki A, Poon LC, Gil M, Wright D: First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Fetal Diagn Ther 2014;35:185-192.